Two Drug ART? — Clinical Considerations

In her recent newsletter issue (eHIV Review V5 #1), Dr. Ethel Weld, Assistant Professor of Medicine, Pharmacology and Molecular Sciences at the Johns Hopkins School of Medicine, analyzed the current research about the potential uses of two-drug ART regimens. Join her now for a case-based discussion about how that new information can affect patient selection in the clinic.

Take our post-test to claim CME credits.

To read a companion newsletter click here.

Leave a Reply

Your email address will not be published. Required fields are marked *